Compile Data Set for Download or QSAR
maximum 50k data
Found 647 of ic50 for UniProtKB: P30419
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50121716((3-methyl-4-(3-(pyridin-3-ylmethylamino)propoxy)be...)
Affinity DataIC50:  0.390nMAssay Description:In vitro inhibitory activity against candida albicans Nmt (CaNmt) using substrate peptide GLTISKLFR-R-NH2 (0.5 uM) and myristoyl-CoA (0.5 uM)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50220561(CHEMBL173370)
Affinity DataIC50:  0.400nMAssay Description:In vitro inhibitory activity against Candida albicans Nmt (CaNmt) using substrate peptide GLTISKLFR-R-NH2 (0.5 uM) and myristoyl-CoA (0.5 uM)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50220562(CHEMBL171506)
Affinity DataIC50:  0.580nMAssay Description:In vitro inhibitory activity against Candida albicans Nmt (CaNmt) using substrate peptide GLTISKLFR-R-NH2 (0.5 uM) and myristoyl-CoA (0.5 uM)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50220565(CHEMBL170524)
Affinity DataIC50:  0.710nMAssay Description:In vitro inhibitory activity against Candida albicans Nmt (CaNmt) using substrate peptide GLTISKLFR-R-NH2 (0.5 uM) and myristoyl-CoA (0.5 uM)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50520331(CHEMBL4445137)
Affinity DataIC50: <1nMAssay Description:Inhibition of human N-myristoyltransferase assessed as reduction in CoASH production by fluorogenic detection based assayMore data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50520331(CHEMBL4445137)
Affinity DataIC50: <1nMAssay Description:Inhibition of human NMT1 by fluorescence methodMore data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50121720((1-METHYL-1H-IMIDAZOL-2-YL)-(3-METHYL-4-{3-[(PYRID...)
Affinity DataIC50:  1.30nMAssay Description:In vitro inhibitory activity against Candida albicans Nmt (CaNmt) using substrate peptide GLTISKLFR-R-NH2 (0.5 uM) and myristoyl-CoA (0.5 uM)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50220569(CHEMBL422896)
Affinity DataIC50:  1.30nMAssay Description:In vitro inhibitory activity against Candida albicans Nmt (CaNmt) using substrate peptide GLTISKLFR-R-NH2 (0.5 uM) and myristoyl-CoA (0.5 uM)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185107(US9156811, DDD100868)
Affinity DataIC50:  2nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50220559(CHEMBL422746)
Affinity DataIC50:  2nMAssay Description:In vitro inhibitory activity against Candida albicans Nmt (CaNmt) using substrate peptide GLTISKLFR-R-NH2 (0.5 uM) and myristoyl-CoA (0.5 uM)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184902(US9156811, DDD86481)
Affinity DataIC50:  3nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184854(US9156811, DDD86206)
Affinity DataIC50:  3nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184848(US9156811, DDD85646)
Affinity DataIC50:  3nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50364113(CHEMBL1230468)
Affinity DataIC50:  3nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50364113(CHEMBL1230468)
Affinity DataIC50:  3nMAssay Description:Inhibition of human N-myristoyltransferase 1 using [3H]myristoyl-CoA and GCGGSKVKPQPPQAK(biotin)-amide as substrate preincubated for 5 mins prior sub...More data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184977(US9156811, DDD88646)
Affinity DataIC50:  3nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50220571(CHEMBL355250)
Affinity DataIC50:  3.5nMAssay Description:In vitro inhibitory activity against Candida albicans Nmt (CaNmt) using substrate peptide GLTISKLFR-R-NH2 (0.5 uM) and myristoyl-CoA (0.5 uM)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50219312(CHEMBL158172)
Affinity DataIC50:  3.70nMAssay Description:Inhibitory activity against Candida albicans (Nmt) assessed as inhibitory concentration (nM)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50219310(CHEMBL155469)
Affinity DataIC50:  3.70nMAssay Description:Inhibitory activity against Candida albicans N-Myristoyltransferase (Nmt)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50109882(3-(3-methyl-2-((2,3,4-trifluorophenoxy)methyl)benz...)
Affinity DataIC50:  3.70nMAssay Description:Inhibitory activity against Candida albicans (Nmt) assessed as inhibitory concentration (nM); 3.7-9.4 nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50109879(CHEMBL155301 | Non peptidic, 4 | {3-[2-(2,3-Difluo...)
Affinity DataIC50:  3.70nMAssay Description:Inhibitory activity against Candida albicans N-Myristoyltransferase (CaNmt) assessed as inhibitory concentration using substrate peptide and myristot...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50219305(CHEMBL347895)
Affinity DataIC50:  3.70nMAssay Description:Inhibitory activity against Candida albicans (Nmt) assessed as inhibitory concentrationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50219303(CHEMBL345893)
Affinity DataIC50:  3.70nMAssay Description:Inhibitory activity against Candida albicans (Nmt) assessed as inhibitory concentration (nM)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50109879(CHEMBL155301 | Non peptidic, 4 | {3-[2-(2,3-Difluo...)
Affinity DataIC50:  3.70nMAssay Description:Inhibitory activity against Candida albicans (Nmt) assessed as inhibitory concentration (nM)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50364113(CHEMBL1230468)
Affinity DataIC50:  4nMAssay Description:Inhibition of human NMT1 using [3H]-myristoyl-coA/biotinylated CAP5.5 as substrate after 15 mins by scintillation/luminescence counting methodMore data for this Ligand-Target Pair
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185092(US9156811, DDD100798)
Affinity DataIC50:  4nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185101(US9156811, DDD100807)
Affinity DataIC50:  4nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184978(US9156811, DDD90022)
Affinity DataIC50:  4nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033480(CHEMBL3357697)
Affinity DataIC50:  4nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033485(CHEMBL3357702)
Affinity DataIC50:  4nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033616(CHEMBL3358119)
Affinity DataIC50:  4nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033418(CHEMBL3357685)
Affinity DataIC50:  4nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033618(CHEMBL3358121)
Affinity DataIC50:  5nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185083(US9156811, DDD100169)
Affinity DataIC50:  5nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184988(US9156811, DDD90107)
Affinity DataIC50:  5nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184943(US9156811, DDD88193)
Affinity DataIC50:  5nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033617(CHEMBL3358120)
Affinity DataIC50:  5nMAssay Description:Inhibition of human NMT1 using [3H]-myristoyl-coA/biotinylated CAP5.5 as substrate after 15 mins by scintillation/luminescence counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184992(US9156811, DDD90118)
Affinity DataIC50:  5nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033482(CHEMBL3357699)
Affinity DataIC50:  5nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50033617(CHEMBL3358120)
Affinity DataIC50:  5nMAssay Description:Inhibition of human N-myristoyltransferase 1 assessed as transfer of [3H]-myristic acid to a biotinylated substrate peptide (GCGGSKVKPQPPQAK(biotin)-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50219312(CHEMBL158172)
Affinity DataIC50:  5.20nMAssay Description:Inhibitory activity against Candida albicans N-Myristoyltransferase (CaNmt) assessed as inhibitory concentration using substrate peptide and myristot...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50109882(3-(3-methyl-2-((2,3,4-trifluorophenoxy)methyl)benz...)
Affinity DataIC50:  5.60nMAssay Description:Inhibitory activity against Candida albicans Nmt (CaNmt)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50109882(3-(3-methyl-2-((2,3,4-trifluorophenoxy)methyl)benz...)
Affinity DataIC50:  5.70nMAssay Description:Inhibitory activity against Candida albicans N-Myristoyltransferase (CaNmt) assessed as inhibitory concentration using substrate peptide and myristot...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185061(US9156811, DDD100144)
Affinity DataIC50:  6nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184937(US9156811, DDD88186)
Affinity DataIC50:  6nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185108(US9156811, DDD100869)
Affinity DataIC50:  6nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM50364135(CHEMBL1951295)
Affinity DataIC50:  7nMAssay Description:Inhibition of human N-myristoyltransferase 1 using [3H]myristoyl-CoA and GCGGSKVKPQPPQAK(biotin)-amide as substrate preincubated for 5 mins prior sub...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM185078(US9156811, DDD100164)
Affinity DataIC50:  7nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184965(US9156811, DDD88558)
Affinity DataIC50:  7nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1(Homo sapiens (Human))
Frontier Medicines

Curated by ChEMBL
LigandPNGBDBM184860(US9156811, DDD86213)
Affinity DataIC50:  7nMpH: 7.4 T: 2°CAssay Description:Measurement of the ability of compounds to inhibit the NMT-1 and/or NMT-2 enzyme isoforms of human, trypanosome (T. brucei), leishmanial (L. major) a...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 647 total ) | Next | Last >>
Jump to: